Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Romiplostim Dose-Finding Study in Refractory Aplastic Anemia
NCT02094417Phase 2Completed
- Sponsor
- Kyowa Kirin
- Start
- Apr 2014
- Primary completion
- Apr 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of romiplostim in aplastic anemia, sponsored by Kyowa Kirin. Started Apr 2014; status: completed.
02
Drugs
romiplostim
03
Conditions
aplastic anemia
Beyond the preview
Go deeper on NCT02094417.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02094417.